Navigation Links
SCOLR Pharma, Inc. Announces Initial Shipments of its Nutritional Products
Date:12/23/2011

BOTHELL, Wash., Dec. 23, 2011 /PRNewswire/ -- SCOLR Pharma, Inc. (OTCQB: SCLR) today announced that it has  received and shipped initial retail orders for its extended-release nutritional products based on the Company's proprietary CDT® oral drug delivery platform. The shipments represent SCOLR's first significant direct retail sales of its nutritional products.

Stephen J. Turner, SCOLR Pharma's President and CEO, said, "Shipment of these initial orders marks an important milestone for SCOLR as we continue to focus on growing our nutritional products business into a sustainable source of revenue. We are gratified by the response we have had with retailers and confident that our products are greeted well by consumers."

Turner said SCOLR intends to provide investors with future updates on its nutritional business activities in conjunction with its quarterly announcements of financial results and in its periodic reports filed with the Securities and Exchange Commission.

About SCOLR Pharma:

Based in Bothell, Washington, SCOLR Pharma, Inc. is a specialty pharmaceutical company focused on applying its formulation expertise and patented CDT platforms to develop novel prescription pharmaceutical, over-the-counter (OTC), and nutritional products. Its CDT drug delivery platforms are based on multiple issued and pending patents and other intellectual property for the programmed release or enhanced performance of active pharmaceutical ingredients and nutritional products. For more information on SCOLR Pharma, please call 425-368-1050 or visit http://www.scolr.com/.

Forward looking statements:                                              

An
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
2. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
3. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
4. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
5. SCOLR Pharma, Inc. Licenses Dietary Supplements
6. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
7. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
8. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
9. SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
10. SCOLR Pharma, Inc. Announces Intention to Voluntarily Delist From NYSE AMEX Exchange
11. SCOLR Pharma, Inc. Common Stock to Begin Trading on OTC Bulletin Board and OTCQB Stock Market on January 13, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... the list of stocks featured in the Analyst Blog. Every ... and events impacting stocks and the financial markets. Stocks recently ... Free Report ), Gilead (Nasdaq: GILD - Free Report ... AbbVie (NYSE: ABBV - Free Report ) and Celgene ... Zacks is promoting its ,Buy, stock recommendations. Get #1Stock ...
(Date:7/31/2014)... -- TB Alliance, a not-for-profit organization with the mission ... (TB), announced the appointment of Elana Robertson ... the organization from Novartis Vaccines, where she was responsible ... Eastern Europe . In her new role, ... beneficial new TB treatments are available and adopted around ...
(Date:7/31/2014)... und KISSING, Deutschland, 31. Juli ... und Distributor eines computerunterstützten („robotischen") Koloskopie-Systems für ... (Homi) Shamir , ein weltweit anerkannter Manager ... und Kontrollgremiums zum Unternehmen stößt. ... Shamir ist ein hochangesehener globaler Visionär ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6TB Alliance Names Elana Robertson Senior Vice President, Market Access 2TB Alliance Names Elana Robertson Senior Vice President, Market Access 3invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 3
... Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") ... appointment of Patrice P. Rioux, M.D., Ph.D., ... will be responsible for the clinical and ... programs.(Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO ...
... to Resubmit Loramyc(R) NDA WOODCLIFF LAKE, N.J., April 9 ... wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: ... two of its pipeline products. Ondansetron Orally ... a New Drug Application (NDA) for its new orally ...
Cached Medicine Technology:Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer 2Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer 3Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer 4Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer 5Strativa Pharmaceuticals Provides Product Pipeline Update 2Strativa Pharmaceuticals Provides Product Pipeline Update 3Strativa Pharmaceuticals Provides Product Pipeline Update 4
(Date:7/31/2014)... (HealthDay News) -- The virus that causes cold sores -- ... absence of symptoms, according to a new study. ... cells of people infected with the virus. This explains why ... why others get them only occasionally. The authors said the ... "We thought when the disease was dormant, it was ...
(Date:7/31/2014)... 2014 Saint Luke’s Health System clinics ... Insight award for Overall Patient Experience in the Clinician ... in multiple categories by HealthStream, Inc.. , Recipients ... in patient care. To qualify for an award, a ... client of HealthStream in 2013, scored in the 75th ...
(Date:7/31/2014)... 2014 Shiitakes have been called “The ... for Quick-Fix Spaghetti Sauce below, they cook up in ... valued for their deep flavor -- four to ten ... of the foods they're cooked with, so they add ... low-fat nutrition. Shiitakes are rich in fiber and contain ...
(Date:7/31/2014)... release is available in German . ... baby blues after giving birth. Some even develop full-blown ... A, an enzyme responsible for the breakdown of neurotransmitters ... this condition. In comparison to healthy women, women who ... enzyme in their brains. This was discovered by a ...
(Date:7/31/2014)... University medical and nursing school researchers hope to ... who participate in clinical trials, a critical step ... , For various reasonsincluding a lack of awareness ... cancer patients take part in trials of experimental ... patients who are eligible still don,t enroll, according ...
Breaking Medicine News(10 mins):Health News:Cold Sore Virus Active Without Symptoms, Study Finds 2Health News:Saint Luke’s Health System Physicians and Clinics Earn Excellence through Insight Awards for Overall Patient Experience in the CG-CAHPS Database 2Health News:Saint Luke’s Health System Physicians and Clinics Earn Excellence through Insight Awards for Overall Patient Experience in the CG-CAHPS Database 3Health News:Quick Fixin’ Summertime Meals with Shiitake Mushrooms -- Bring ‘em Home and Grow Your Own 2Health News:Quick Fixin’ Summertime Meals with Shiitake Mushrooms -- Bring ‘em Home and Grow Your Own 3Health News:Monoamine oxidase A: Biomarker for postpartum depression 2Health News:Monoamine oxidase A: Biomarker for postpartum depression 3Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 2Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 3
... and Clinical Research of the American College ... American College,of Gastroenterology and its Institute for Clinical ... million over four years by Salix,Pharmaceuticals, Inc. The ... Advancing Excellence campaign to provide long-term support for ...
... 2007) -- Experts called on government and medical organizations ... most serious public health policy errors in the history ... Blumberg, M.D. and Joanna M. Heal, M.D., specialists in ... Medical Center, urged that universal adoption of leukocyte reduction, ...
... that mesalamine use among patients with inflammatory bowel disease ... cancer when comparing cases and controls. In the ... the American College of Gastroenterology, researchers from Henry Ford ... and Crohns disease to 23 controls with similar body ...
... October 15, 2007 Post-hoc and other analyses ... study of Shire plc,s (LSE: SHP, NASDAQ: SHPGY, TSX: ... data on LIALDA in patients with mild to moderate ... long-term, Phase III, open-label 12-14 month extension study, are ...
... may be the,ultimate plaque fighting tool, but it also ... and GfK Roper reveals that more than half,(54 percent) ... on,the bathroom floor, despite voting the bathroom as the ... In addition, nine percent of men,admitted to reusing their ...
... Strengthen Strategic Consulting ... Canada, MOUNTAIN VIEW, Calif., Oct. 15 ... of software,strategic consulting, and regulatory services for optimizing ... scientific consulting,services practices with three new hires. Pharsight ...
Cached Medicine News:Health News:ACG Announces Major Gift by Salix Pharmaceuticals, Inc. 2Health News:Leukocyte reduction seen as significant advance in transfusion medicine 2Health News:Leukocyte reduction seen as significant advance in transfusion medicine 3Health News:Mesalamine linked to cancer protection for high risk inflammatory bowel disease patients 2Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 2Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 3Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 4Health News:New Survey Uncovers Dirty Little Secrets About America's Oral Care Habits 2Health News:New Survey Uncovers Dirty Little Secrets About America's Oral Care Habits 3Health News:Pharsight Expands Global Consulting Services Teams 2Health News:Pharsight Expands Global Consulting Services Teams 3
... is IMPACs comprehensive information system designed ... to integrate and streamline their diagnostic, ... single, intuitive software solution. Thousands of ... institutions have proven PowerPaths unique "case-centric ...
The most compact revolutionary innovation in hematology. Automated and fully-integrated slide preparation and staining system....
... The Digital-Photo Adapter DC ... optics for the BQ ... In combination with a ... is the best choice ...
... A constant excellent illumination (150'000 ... to adjust the length of the ... continuously form 0.2 to 8 mm ... a slit mechanism allowing hairline settings ...
Medicine Products: